EKIMAS Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ASNB research report →
Price Chart
About the company
Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction.
- CEO
- Henrik Rouf
- IPO
- 1996
- Employees
- 11
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on ASNB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.83M
- P/E
- -14.68
- PEG
- -0.37
- P/S
- 0.00
- P/B
- 1.25
- EV/EBITDA
- -16.92
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -4.38%
- ROIC
- -3.34%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-4,370,998
- Net Income
- $559+100.0%
- EPS
- $-0.22+31.3%
- OCF Growth
- -243.0%
- FCF Growth
- -244.4%
- 52W High
- $1.70
- 52W Low
- $0.55
- 50D MA
- $0.80
- 200D MA
- $0.92
- Beta
- -0.58
- RSI (14)
- 56
- Avg Volume
- 2.06K
No earnings-call transcripts are available for ASNB yet.
- Free Float
- 0.0%
- Shares Outstanding
- 5.68M
- Float Shares
- 0
Our ASNB coverage
Recent articles, reports, and earnings notes.
No research on ASNB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ASNB report →